2007

1. Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 trial

   Journal of Clinical Oncology, Vol. 25, Núm. 1, pp. 16-24

2. Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia

   European Journal of Haematology, Vol. 78, Núm. 2, pp. 102-110